{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:59Z","timestamp":1707524279559},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,15]]},"DOI":"10.7759\/cureus.16411","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T22:38:02Z","timestamp":1626388682000},"source":"Crossref","is-referenced-by-count":1,"title":["Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid"],"prefix":"10.7759","author":[{"given":"Naomichi","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Ikenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103435","article-title":"Understanding the pathophysiology of cerebral amyloid angiopathy","volume":"21","author":"Gatti L","year":"2020","unstructured":"Gatti L, Tinelli F, Scelzo E, et al.. Understanding the pathophysiology of cerebral amyloid angiopathy. Int J Mol Sci. 2020, 21:3435. 10.3390\/ijms21103435","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou A","year":"2017","unstructured":"Charidimou A, Boulouis G, Gurol ME, et al.. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017, 140:1829-50. 10.1093\/brain\/awx047","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.012999","article-title":"Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment","volume":"47","author":"Case NF","year":"2016","unstructured":"Case NF, Charlton A, Zwiers A, et al.. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke. 2016, 47:2010-6. 10.1161\/STROKEAHA.116.012999","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.4.537","article-title":"Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria","volume":"56","author":"Knudsen KA","year":"2001","unstructured":"Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001, 56:537-9. 10.1212\/wnl.56.4.537","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.2.172","article-title":"Comparison of mania and depression after brain injury: causal factors","volume":"145","author":"Robinson RG","year":"1988","unstructured":"Robinson RG, Boston JD, Starkstein SE, Price TR. Comparison of mania and depression after brain injury: causal factors. Am J Psychiatry. 1988, 145:172-8. 10.1176\/ajp.145.2.172","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2006.01470.x","article-title":"Mania after vascular dementia in a patient with bipolar II disorder","volume":"60","author":"Watanabe Y","year":"2006","unstructured":"Watanabe Y, Shioiri T, Kuwabara H, Someya T. Mania after vascular dementia in a patient with bipolar II disorder. Psychiatry Clin Neurosci. 2006, 60:117-8. 10.1111\/j.1440-1819.2006.01470.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198802000-00004","article-title":"Mechanisms of mania after brain injury. 12 case reports and review of the literature","volume":"176","author":"Starkstein SE","year":"1988","unstructured":"Starkstein SE, Boston JD, Robinson RG. Mechanisms of mania after brain injury. 12 case reports and review of the literature. J Nerv Ment Dis. 1988, 176:87-100. 10.1097\/00005053-198802000-00004","journal-title":"J Nerv Ment Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham LN","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018, 20:97-170. 10.1111\/bdi.12609","journal-title":"Bipolar Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104091","article-title":"Efficacy and safety of valproic acid in dementia: a systematic review with meta-analysis","volume":"89","author":"Liu J","year":"2020","unstructured":"Liu J, Wang LN. Efficacy and safety of valproic acid in dementia: a systematic review with meta-analysis. Arch Gerontol Geriatr. 2020, 89:104091. 10.1016\/j.archger.2020.104091","journal-title":"Arch Gerontol Geriatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.04.009","article-title":"Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage","volume":"11","author":"Martinez-Ramirez S","year":"2015","unstructured":"Martinez-Ramirez S, Romero JR, Shoamanesh A, et al.. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015, 11:1480-8. 10.1016\/j.jalz.2015.04.009","journal-title":"Alzheimers Dement"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22112","article-title":"Cerebral amyloid angiopathy pathology and cognitive domains in older persons","volume":"69","author":"Arvanitakis Z","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011, 69:320-7. 10.1002\/ana.22112","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.2.170","article-title":"Affective disorders and cerebral vascular disease","volume":"154","author":"Starkstein SE","year":"1989","unstructured":"Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry. 1989, 154:170-82. 10.1192\/bjp.154.2.170","journal-title":"Br J Psychiatry"},{"key":"ref13","article-title":"Pharmacology of valproate","volume":"37 Suppl 2","author":"Owens MJ","year":"2003","unstructured":"Owens MJ, Nemeroff CB. Pharmacology of valproate. Psychopharmacol Bull. 2003, 37 Suppl 2:17-24.","journal-title":"Psychopharmacol Bull"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease","volume":"51","author":"Xuan AG","year":"2015","unstructured":"Xuan AG, Pan XB, Wei P, et al.. Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease. Mol Neurobiol. 2015, 51:300-12. 10.1007\/s12035-014-8751-4","journal-title":"Mol Neurobiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.09.031","article-title":"Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-\u03b2 oligomers released from 7PA2 cells","volume":"128","author":"Williams RS","year":"2018","unstructured":"Williams RS, Bate C. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-\u03b2 oligomers released from 7PA2 cells. Neuropharmacology. 2018, 128:54-62. 10.1016\/j.neuropharm.2017.09.031","journal-title":"Neuropharmacology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64464-cerebral-amyloid-angiopathy-with-a-hypomanic-episode-treated-with-valproic-acid","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:38Z","timestamp":1707507158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64464-cerebral-amyloid-angiopathy-with-a-hypomanic-episode-treated-with-valproic-acid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.16411","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}